AGA Clinical Trials | Hialeah, FL
Status and phase
Conditions
Treatments
About
This is a phase Ib, randomized, double-blind, placebo-controlled study to evaluate safety, tolerability, efficacy and pharmacokinetics of ASC10 tablets in mild or moderate COVID-19 subjects.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
32 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Handan He, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal